The label carries a warning about the potential for hypersensitivity reactions to<unk> . The following adverse effects in at least 2% more people given the drug than were given placebo: bruising, gait disturbances, headache, skin inflammation, eczema, problems breathing, excess sugar in urine, and fungal skin infections.
Edaravone
Molindone
Delavirdine
Nintedanib
Ablomin
Vatalanib
Bexarotene
Triazoledione